Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
SST Networking, Security & Data sharing. Horizon Europe TOP5 (HE23-24 TOP5)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Digital, Industry and Space
Theme: Cluster 4 other
Destination: Other Digital, Industry and Space destinations
Action type: Research and Innovation actions
Countries involved: Spain,France,Poland,Germany,Greece
Call: SST Networking, Security & Data sharing (HORIZON-CL4-2025-SSA-SST-IBA, 2025)
Start date: 2026-01-01
End date: 2028-06-30
Duration (months): 30.0
Total project cost (EUR): 7000000.0
EU funding (EUR): 7000000.0
Participants: 7
Project status: SIGNED

SST Networking, Security & Data sharing The HE_EUSST_SD_TOP5 project address the following actions defined in the Horizon Europe Work Program 2023-2024 • Update operation centres to improved current services (Collision Avoidance; Fragmentation; Re-entry) adapted to future user needs and space environment. • Update operation centres to new missions and services (e.g. debris mitigation; debris remediation). • Adapt the European SST network to a more efficient coordinated scheduling and tasking of the resources and assets. • Develop new data sharing and fusion strategies and techniques adapted to both ground-based and space-based SST assets. • Develop threat analysis and counter-measures to protect the EUSST infrastructure. • Adapt EUSST operation centres for increasing security and resiliency. Coordinated under the umbrella of the Expert Team System Evolution (ETSE) and in close cooperation with the other Expert Teams, the project constitutes of the following activities: - R&D activities related to the EU SST Catalogue, covering for example covariance realism and improved orbit determination - Improvements to the storage and sharing of SST and sensor data in the EU SST Database - Further development of the EU SST scheduler COPLA, including better integration into other system components

Keywords: eusst,sst,partnership,services,assets,sensors,radars,telescopes,catalogue,collision avoidance,re entry,fragmentation,survey,tracking,autonomy
Introducing a new standard for gene editing validation to unleash the full potential of cell and gene therapies (LockSeq)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: Sweden
Call: EIC Accelerator 2025 - Short application (HORIZON-EIC-2025-ACCELERATOR-01, 2025)
Duration (months): 24.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 1
Project status: CLOSED

Cell and gene therapies (CGT) hold the promise of enormous benefits compared to conventional medicine, including the treatment and potential cure of diseases that currently have no clinical treatment, improved and more sustained therapeutic outcomes of a single administration, and reduced side effects. A critical challenge in CGTs lies in accurately assessing the efficiency and specificity of gene edits—a mandatory step during discovery, preclinical, and clinical phases to ensure safety, efficacy, and reproducibility. Existing validation techniques lack a standardized framework. Each gene editing project — whether targeting a specific genetic disorder, optimizing CRISPR-based modifications, or refining base-editing approaches — demands unique validation protocols tailored to its specific parameters. As a result, gene editing R&D demands continuous workflow customization for each use case, leading to high costs, long timelines, and huge inefficiencies. Countagen pinpoints this problem by introducing a breakthrough standardized gene analysis technology, capable of genome-wide and targeted analysis to characterize gene editing outcomes: LockSeq. Countagen’s technology offers a universal, streamlined, and cost-efficient solution for sequencing and locating gene edited sites, providing accurate, detailed and reliable sequencing analysis within two days. No company has yet developed a standardized, phase appropriate technology capable of analyzing genome-wide and target-specific outcomes with an unbiased PCR-free and standardized workflow, producing full characterization within two working days. The impact of Countagen’s novel gene analysis technology enables radically faster discovery and development roadmaps. Ultimately, more precision CGT will be approved, catering to millions of patients that currently have no cure. With LockSeq, Countagen is set on course toIntroducing a new standard for gene editing validation to unleash the full potential of cell and gene therapies

Keywords: cell and gene therapy,next generation sequencing,rolling circle amplification,cell and gene therapy validation,gene editing
Capturing and cONtrolling coniCal intErsections in Real Time (CONCERT)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Synergy grants
Action type: ERC actions
Countries involved: Italy,United States
Call: ERC SYNERGY GRANTS (ERC-2025-SyG, 2025)
Start date: 2026-04-01
End date: 2032-03-31
Duration (months): 72.0
Total project cost (EUR): 9998941.0
EU funding (EUR): 9998941.0
Participants: 5
Project status: SIGNED

Conical intersections (CIs) are regions in the potential energy surface of molecules where different electronic energy levels intersect, leading to the breakdown of the Born-Oppenheimer approximation and promoting non-adiabatic transitions between electronic states. CIs preside over essential ultrafast processes in photobiology, photochemistry, and materials science as they can be viewed as “doorways” through which a photoexcited vibrational wave packet (WP) is efficiently funnelled to a lower-energy electronic state. Despite theoretical predictions, CIs have been experimentally elusive so far, due to the extreme speed of the processes leading to and occurring at the CIs and to the associated large variation in the energetic landscape of the molecule, calling for extreme spectral and temporal resolutions. Leveraging recent experimental advances in the generation of ultrashort soft X-ray pulses and conceptual advances in nonlinear optical spectroscopy, CONCERT aims to: i) directly visualise the very moment in which the molecular WP passes through the CI and the associated quantum mechanical electronic coherences; ii) use this knowledge to control, using tailored light pulses, the WP dynamics in the vicinity of a CI and, ultimately, the outcome and the yield of a photochemical reaction by operating exactly where the fate of the process is decided. CONCERT will have both fundamental and applied impact. On the one hand, it will enable the understanding of the molecular mechanisms driving the passage of a WP through a CI, advancing our knowledge of nature and providing design guidelines for artificial molecular systems that mimic the natural ones. On the other hand, it will offer the ability to control the rates and branching ratios of photochemical processes by manipulating the excited state WP in the critical region that determines its ultimate path, fulfilling the long-held dream of using light as a photonic catalyst to control the outcome of chemical reactions.

Keywords: ultrafast spectroscopy conical intersections quantum dynamics
Magallanes Energy Tidal Platform (ATIR 2.0)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: Spain
Call: EIC Accelerator 2024 - Short application (HORIZON-EIC-2024-ACCELERATOR-01, 2024)
Duration (months): 24.0
Total project cost (EUR): 1680000.0
EU funding (EUR): 1680000.0
Participants: 1
Project status: SIGNED

Tidal stream energy is a form of renewable energy harnessed from the ocean tides. It works by capturing the kinetic energy of tidal movements and converting them into electricity. This process involves using tidal turbines, similar to underwater wind turbines, which rotate as tides flow in and out. The predictability of tidal patterns offering consistent power generation with minimal environmental impact. Magallanes Renovables S.L. is a pioneering company dedicated to developing tidal energy technologies. Since its inception in 2009, the company has focused on creating, refining, and commercializing a cost-effective solution for tidal energy generation. By integrating established technologies from the naval and wind power industries, we have developed an economical and efficient system This project will fund the tests needed for an effectively validation of the platform and the process of industrialization. This validation is crucial as it will demonstrate the platform's effectiveness, reliability, and economic viability under real-world conditions. It's a critical step before the platform can be considered for larger-scale deployment. The project will involve the next phase in engineering and industrialization procedure. This will allow establishment of the first pilot array projects (awarded in Wales and Scotland) that will utilize the ATIR 2.0 technology. The project will also contribute to the advancement of Magallanes Renovables' commercialization and corporate strategy, involving the processes and strategies required to bring the technology to market. Following the invaluable lessons learned from thousands of hours of real-scenario testing, Magallanes Renovables have designed a commercial platform known as the ATIR 2.0 that will advance from TRL7-8 at the project's inception (based on the existing full-scale ATIR 1.0 prototype) to a validated commercial product. Magallanes’ ATIR 2.0 delivers high energy output with low installation and maintenance costs.

Keywords: tidal,marine energy
The first-ever mask-based technology for faster, precise, and sustainable printing of 3D interconnects for the display and semiconductor packaging industry. (Impulse Printing)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Challenges
Action type: EIC actions
Countries involved: Netherlands
Call: Enabling the smart edge (HORIZON-EIC-2024-ACCELERATOR-02, 2024)
Start date: 2025-01-01
End date: 2026-12-31
Duration (months): 24.0
Total project cost (EUR): 3492908.54
EU funding (EUR): 2445035.98
Participants: 2
Project status: SIGNED

At Fonontech, our vision is to pioneer a transformative and sustainable era in semiconductor packaging industry through our proprietary cutting-edge technology, Impulse Printing. Originating from extensive research and development at the Dutch leading Applied Research Institute TNO, the Impulse Printing technology has the unprecedented scalability, accuracy, and throughput for both 2D and 3D interconnect printing for the billion-dollar semiconductor and micro-LED packaging industry. The technology can attain feature sizes ranging from <10 µm to >100 µm in 3D, with the highest throughput and lowest cost of ownership, providing major competitive edge particularly in the critical lower feature range essential for enabling product miniaturization. Impulse Printing, distinguished by minimal cost of ownership and facility footprint, is safeguarded by 14 patents. It is slated for direct sales to high-volume electronic device manufacturers or through system integrators securing the company a revenue of €533 M by 2030.

Keywords: semiconductor packaging technology,cutting edge printing technology,micro led packaging industry
Groundbreaking biocontrol solutions for a resilient agriculture (VERANO)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Challenges
Action type: EIC actions
Countries involved: France
Call: EIC Accelerator Challenge: Novel technologies for resilient agriculture (HORIZON-EIC-2023-ACCELERATOR-01, 2023)
Start date: 2024-07-01
End date: 2028-06-30
Duration (months): 48.0
Total project cost (EUR): 5597993.75
EU funding (EUR): 2499999.0
Participants: 1
Project status: SIGNED

Pertinent is developing products that combine the effectiveness of chemical pesticides with the safety of biocontrol products. Pertinent is applying to a blended funding program combining €2.5M of grants and €6M in direct investment to cover commercialization of its first products and its accelerated growth journey in the crop protection market. The funding coming from the EIC Accelerator Challenge 2023: Novel technologies for resilient agriculture will be critical to help Pertinent accomplish the following steps: conduct the final studies to lock the product formulation for EU and the US; register the active substance and get market authorisations; build a commercialization organization in the EU and US; successfully launch the selected products in the targeted crops for EU, USA and Brazil and Mexico; build production capabilities in France to supply the growing demand (€10M in CapEx); build a R&D lab to formulate the new products, test them and conduct analytical studies (€2M in CapEx). The main milestones of the project are: • 2024: Launch of first crop protection biocontrol products in California (grape vines and berries); • 2025: Temporary market authorisation in Eu for sugar beets and grape vines; first launch in Mexico; • 2028: Launch in Europe under full market authorisation. Pertinent has already established a network of partners in Europe and in the USA that will support its business efforts and have written letters of support in R&D (Universities, testing labs), manufacturing (suppliers and contract manufacturers), field testing and validation (Technical institutes) and commercialization (Distribution agreement already signed for Europe with De Sangosse). Prominent investors have also expressed in written LOI their strong interest in participating in the next round of funding along the EIC. The expected outcomes of the program are the successful launch of one or two products in the EU, the USA and Brazil and Mexico, generating €24.7M of sales in 2028.

Keywords: crop protection,nature derived pest control solutions,breakthrough,revolutionary
Increased efficiency and service life of paper machines through innovative high-tech approaches to repair and optimization (ENHANCE-PAPER)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: Germany
Call: EIC Accelerator 2024 - Short application (HORIZON-EIC-2024-ACCELERATOR-01, 2024)
Duration (months): 24.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 1
Project status: SIGNED

JAEGER GmbH Cylinder Service was founded 1995 in Germany. The primary goal and core business has since been the on-site refurbishment and optimization of rotating cylinders in the paper industry. The services offered by JAEGER GmbH have been very wellreceived on the market in Europe and the Americas. As a result, JAEGER has been able to grow continuously in the past and serves alarge and growing international customer base. Paper manufacturing is a very energy intensive process. Especially under the light of rising energy and CO2 emission cost, competitiveness on the market for paper depends on lowering the manufacturing costs. In the tissue paper industry, the key element in the tissue machine, by means of energy consumption, is the so-called Yankee dryer. Customers in the paper industry have therefore very high requirements for uniform surface roughness and precise geometry for optimum thermal conductivity. To achieve longer service life in modern machines coatings are cruical to become harder and improve wear and corrosion resistance. The process we have developed uniquely combines measurement with μm-precise resolution, production of an optimized surface geometry using innovative tangential grinding processes and precise recoating with the latest coating processes and materials. This enables us to apply very dense and hard coatings that are otherwise difficult to process, resulting in excellent wear and corrosion resistance. In addition, our technology has an active noise and dust prevention system that significantly reduces noise emissions and health risks for workers in industrial practice. Our process is also mobile, on-site capable, and therefore unique in this combination. All these technologies allow an increase in energy efficiency (up to 20%), an extension of the service intervals of the Yankee and reduced downtime for maintenance, therefore supporting Green Deal policies and the competitiveness of the European paper industry.

Keywords: pulp and paper,paper machines,efficiency,cylinder repair,surface technology,yankee dryer
Protein Resource for Industrial Scalable Manufacturing of Eco-textiles (PRISME)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: United Kingdom
Call: EIC Accelerator 2025 - Short application (HORIZON-EIC-2025-ACCELERATOR-01, 2025)
Duration (months): 24.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 1
Project status: SIGNED

PACT Earth, a UK startup founded in 2019, develops sustainable bio-based materials for fashion and other industries using their innovative technological platform. Their flagship product, Oval, is made from collagen derived from industrial fish waste, replacing synthetic fabrics and leather. Oval offers superior performance, customizable aesthetics, and eco-friendly production. Validated by leading luxury fashion brands, Oval targets applications in handbags, footwear, furniture, and automotive interiors. PACT’s patented chemistry and engineering allow Oval to be produced using existing textile manufacturing equipment, minimizing capital expenditure. Partnerships with European manufacturers, like Limonta and Curtidos Badia, support efficient scaling. The production process is energy-efficient, compliant with strict environmental standards, and costs 30% less than traditional leather. Initially targeting the €7.5B luxury fashion market, PACT plans to expand into mass-market and industrial applications by 2028. With projected pricing at €50 per sqm, reducing to €31 per sqm with scaling, PACT aims to capture a significant share of the €1.62 trillion global textiles market. PACT has achieved key milestones: TRL5 development, €9.3M funding, and a pilot facility producing 2,000 sqm per month. Additional funding, including €2.5M from an EIC grant and a Series A round, will support scaling to 5,000 sqm per day by 2028. The company’s mission is to create earth-positive biomaterials that meet human needs while protecting the planet, advancing sustainable innovation in textiles. PACT's low-cost, sustainable solution positions it as a leader in the shift toward environmentally responsible materials, offering brands a superior and environmentally conscious alternative.

Keywords: sustainable textile,alternative leather,waste to value,biomaterial platform,collagen based biomaterial
A user-centric, digital drainage system and remote monitoring for treating malignant pleural effusion (MPE) (releaze)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: Ireland
Call: EIC Accelerator 2024 - Short application (HORIZON-EIC-2024-ACCELERATOR-01, 2024)
Duration (months): 24.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 1
Project status: SIGNED

SymPhysis Medical is an Irish start-up that is developing a breakthrough solution for managing malignant pleural effusion (MPE), fluid in the chest resulting from terminal cancers. MPE, or “fluid on the lung”, is defined as the accumulation of significant exudate in the pleural space, accompanied by the presence of malignant cells or tumour tissue. Normally, the chest cavity (space outside of the lung but inside the chest wall) has 4-5 teaspoons of fluid which provides space for the lungs to expand and plays a role in normal respiratory mechanics. However, in certain cancer patients, inflammatory processes in the body can cause as much as 2-3 litres of fluid to build up in the chest cavity, which puts pressure on the lungs and diaphragm. An estimated 400k new diagnoses of MPE are made in the EU and 200k US each year. SymPhysis Medical intends to set a new standard of care for MPE treatment by providing a patient-centric, digital drainage solution that aims to: provide a shorter and more predictable treatment by targeting catheter removal within 30 days, as opposed to up to 12 months with current IPCs; provide a streamlined approach to insertion requiring only one incision, potentially halving the insertion procedure time; incorporate a more user-friendly design with features that enable a ‘one- handed’ drainage step, and an ‘autostop’ feature, thus enabling patient autonomy and comfort and making IPC treatment accessible to more patients; provide 25% cost savings relating to home-related costs, due to fewer drainage supplies and reduced risk of catheter-related complications; provide the first ever remote monitoring platform that improves patients quality of life and supports this vulnerable population at home.

Keywords: mpe malignant pleural effusion cancer digital drainage independence quality of life palliative care
Prebona Disinfect K - the first nanotechnology-based surface disinfectant with a sustained antimicrobial effect (PrebonaDisinfectK)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Other destinations
Action type: EIC actions
Countries involved: Sweden
Call: EIC Accelerator 2024 - Short application (HORIZON-EIC-2024-ACCELERATOR-01, 2024)
Duration (months): 24.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 1
Project status: SIGNED

Prebona is developing Prebona Disinfect K, the first nanotechnology-based surface disinfectant with a sustained antimicrobial effect. The COVID-19 pandemic underscored the critical importance of effective surface disinfection in managing public health. Frequently touched surfaces can harbor pathogens, heightening the risk of disease transmission. Despite the availability of various disinfectants like alcohol, their effectiveness is limited by short-term protection and compliance challenges, as alcohol evaporates quickly, leaving surfaces vulnerable to recontamination. Prebona Disinfect K addresses this existing gap on the market by uniquely combining long-term efficacy against viruses, bacteria, and fungi, ease of use, safety for humans and the environment and a sustainable, zero-waste production process. The product is developed based on the Prebona CompoTech nanotechnology platform, allowing for atomic-level precision in modifying silica particles' size and quantity, as well as the number and type of active ingredients attached to them. Initial tests of Prebona Disinfect K show a 99.999% antimicrobial effect after 24 hours and several abrasion cycles that mimic everyday usage like cleaning, touching and wiping. Designed to address the global need for more hygienic environments, Prebona Disinfect K aims to reduce the spread of infectious diseases via surface contact, mitigating the impacts of future pandemics. In the EIC Accelerator project we will perform molecular redisigning of the product to maximise its stability, manufacturability, and performance. We will expand pathogen testing and conduct market-specific trials to confirm Prebona Disinfect K's effectiveness. The formulation and packaging will be optimized to ensure compliance with EU BPR regulation. Pilot sales will help gather feedback and grow our user base. We'll scale up production to meet demand, positioning our company to capture a significant share of the European surface disinfectants market.

Keywords: surface disinfection,nanotechnology,anti microbial effect,public health